[Breaking] Lemon Healthcare (listed on KOSDAQ on July 6) is trading at 15,550 won as of 9:00 AM on its first day of listing. This represents a 55.50% increase from the initial public offering price of 10,000 won. As a software company leveraging medical MyData-based platform technology, it is attracting investor attention amid the expansion of the digital healthcare industry.

KB Securities served as the lead underwriter. The company drew market attention even before its listing by recording high competition rates during the institutional book-building and public subscription processes. The public subscription for retail investors took place from June 24 to 25, with a final overall subscription competition rate of 1,510.57 to 1. Based on KB Securities, the final proportional allocation competition rate was 3,020.14 to 1, with a total of 313,347 subscription applications.

Real-Time Bidirectional Medical MyData Relay Platform as Core Competitiveness

Lemon Healthcare's core competitive advantage lies in its real-time bidirectional medical MyData relay platform. The company operates a platform business that relays medical data for use by various institutions, including not only smart hospital services connecting patients with medical institutions but also insurance companies, pharmacies, pharmaceutical firms, financial institutions, and healthcare companies.

The company's core technology, LDB (Lemon Digital Bridge), is a medical MyData relay platform that securely collects patients' medical data and converts it in real time into the format requested by demand-side institutions. A key feature is that the entire process of data collection and delivery is handled within a single platform.

Platform Comprising Three Business Areas

• The business is largely divided into three areas:
• LDB-H: A smart hospital platform connecting medical institutions and patients
• LDB-E: Securely linking medical data to insurance, pharmaceutical, pharmacy, and financial sectors
• LDB-D: Providing customized health data processed through analysis and refinement in API format

In particular, LDB-D is expanding its scope of application as a platform that supports the development of personalized health management services and AI-based health data analysis services. Some assessments suggest it could serve as a new growth driver if the market for medical data utilization expands.

Market Outlook

The market is closely watching Lemon Healthcare's potential for business expansion, particularly if the government's policies on medical data utilization continue to broaden and the digital healthcare industry maintains its growth trajectory. However, during the early stages of listing, stock price volatility may increase depending on IPO supply and demand dynamics and overall market sentiment, requiring cautious approaches from investors.

---

[This article was written with AI assistance. This article is not intended to solicit investment, and investment decisions and their associated responsibilities rest solely with the investor.]